Correlation Between Medicure and Elite Pharma
Can any of the company-specific risk be diversified away by investing in both Medicure and Elite Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Medicure and Elite Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Medicure and Elite Pharma, you can compare the effects of market volatilities on Medicure and Elite Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Medicure with a short position of Elite Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Medicure and Elite Pharma.
Diversification Opportunities for Medicure and Elite Pharma
-0.44 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Medicure and Elite is -0.44. Overlapping area represents the amount of risk that can be diversified away by holding Medicure and Elite Pharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Elite Pharma and Medicure is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Medicure are associated (or correlated) with Elite Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Elite Pharma has no effect on the direction of Medicure i.e., Medicure and Elite Pharma go up and down completely randomly.
Pair Corralation between Medicure and Elite Pharma
If you would invest 3.73 in Elite Pharma on September 13, 2024 and sell it today you would earn a total of 0.00 from holding Elite Pharma or generate 0.0% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Very Weak |
Accuracy | 1.59% |
Values | Daily Returns |
Medicure vs. Elite Pharma
Performance |
Timeline |
Medicure |
Elite Pharma |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Medicure and Elite Pharma Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Medicure and Elite Pharma
The main advantage of trading using opposite Medicure and Elite Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Medicure position performs unexpectedly, Elite Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Elite Pharma will offset losses from the drop in Elite Pharma's long position.Medicure vs. Grey Cloak Tech | Medicure vs. CuraScientific Corp | Medicure vs. Love Hemp Group | Medicure vs. Greater Cannabis |
Elite Pharma vs. Amarantus Bioscience Holdings | Elite Pharma vs. Intelgenx Technologs | Elite Pharma vs. Cytosorbents Crp |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.
Other Complementary Tools
Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
Bonds Directory Find actively traded corporate debentures issued by US companies | |
Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities |